Similarly, identification of CFTR or ADGRG2 mutations in patients with CBAVD has direct implications for assisted reproductive technology (ART), such as intracytoplasmic sperm injection (ICSI) and preimplantation genetic testing (PGT). This evidence concerns the gene CFTR and congenital bilateral aplasia of vas deferens from CFTR mutation.